U.S. markets closed
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • Dow 30

    30,932.37
    -469.64 (-1.50%)
     
  • Nasdaq

    13,192.35
    +72.92 (+0.56%)
     
  • Russell 2000

    2,201.05
    +0.88 (+0.04%)
     
  • Crude Oil

    61.66
    -1.87 (-2.94%)
     
  • Gold

    1,733.00
    -42.40 (-2.39%)
     
  • Silver

    26.70
    -0.98 (-3.56%)
     
  • EUR/USD

    1.2088
    -0.0099 (-0.81%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • GBP/USD

    1.3922
    -0.0091 (-0.65%)
     
  • USD/JPY

    106.5500
    +0.3200 (+0.30%)
     
  • BTC-USD

    44,838.68
    -2,310.42 (-4.90%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

WHO expected to review AstraZeneca COVID-19 vaccine on Feb. 8 - expert

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

GENEVA, Jan 26 (Reuters) - The World Health Organization's vaccine advisory panel has tentatively scheduled a review of the Astrazeneca COVID-19 vaccine for February 8, an expert said on Tuesday.

"Reviewing the data from AstraZeneca, and we have tentatively - I have to underline tentatively - scheduled a meeting of SAGE to discuss policy recommendation on February 8th," Joachim Hombach, executive secretary of WHO's Strategic Advisory Group of Experts on Immunisation (SAGE), told a news briefing held as it issued recommendations on the use of the Moderna vaccine.

(Reporting by Stephanie Nebehay; editing by Matthias Blamont in Paris)